Skip to content
zameds

Isoniazid, pyrazinamide, rifampicin (Co-afaris Paed, Co-ripyso Paed, Co-orizit Paed)

Isoniazid, pyrazinamide, rifampicin

Macleods Pharmaceuticals SA (Pty) Ltd

Registration

Applicant
Macleods Pharmaceuticals SA (Pty) Ltd
Registrations
3

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Co-afaris paed 75/50/150 tablets

EACH TABLET CONTAINS:ISONIAZID 50,0 mg; PYRAZINAMIDE 150,0 mg; RIFAMPICIN 75,0 mg

75/50/150Tablets52030652/20.2.3/0306RegisteredNot determinedNone
Co-ripyso paed 75/50/150 tablets

EACH TABLET CONTAINS ISONIAZID 50,0 mg, PYRAZINAMIDE 150,0 mg, RIFAMPICIN 75,0 mg

75/50/150Tablets520307.30652/20.2.3/0307.306RegisteredNot determinedNone
Co-orizit paed 75/50/150 tablets

EACH TABLET CONTAINS ISONIAZID 50,0 mgPYRAZINAMIDE 150,0 mgRIFAMPICIN 75,0 mg

75/50/150Tablets520308.30652/20.2.3/0308.306CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Isoniazid

    Consolidated Schedules 06 July 2026, line 6819

  • S4: Pyrazinamide

    Consolidated Schedules 06 July 2026, line 7685

  • S4: Rifampicin

    Consolidated Schedules 06 July 2026, line 7802

  • S3: Pyrazinamide

    • when intended for oral use.

    Consolidated Schedules 06 July 2026, line 4189

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

Combination product

This product contains more than one active ingredient, so it has no single molecular structure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles